Parametric Portfolio Associates LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 2.5% in the third quarter, HoldingsChannel reports. The firm owned 3,107,622 shares of the company’s stock after acquiring an additional 76,235 shares during the quarter. Parametric Portfolio Associates LLC’s holdings in Colgate-Palmolive were worth $226,390,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Trust Co. of Toledo NA OH lifted its position in Colgate-Palmolive by 8.2% in the second quarter. Trust Co. of Toledo NA OH now owns 5,487 shares of the company’s stock valued at $407,000 after acquiring an additional 417 shares during the last quarter. Peak Capital Management LLC purchased a new stake in Colgate-Palmolive in the second quarter valued at $204,000. Fisher Asset Management LLC lifted its position in Colgate-Palmolive by 793.3% in the second quarter. Fisher Asset Management LLC now owns 236,799 shares of the company’s stock valued at $17,554,000 after acquiring an additional 210,290 shares during the last quarter. National Pension Service lifted its position in Colgate-Palmolive by 8.8% in the second quarter. National Pension Service now owns 652,934 shares of the company’s stock valued at $48,395,000 after acquiring an additional 53,000 shares during the last quarter. Finally, Forte Capital LLC ADV lifted its position in Colgate-Palmolive by 5.0% in the second quarter. Forte Capital LLC ADV now owns 6,260 shares of the company’s stock valued at $464,000 after acquiring an additional 300 shares during the last quarter. Hedge funds and other institutional investors own 72.85% of the company’s stock.

A number of brokerages recently weighed in on CL. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research report on Tuesday, January 16th. Jefferies Group reissued a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Royal Bank of Canada reissued a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Citigroup reduced their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research report on Thursday, November 2nd. Finally, KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $76.45.

In related news, Director Stephen I. Sadove sold 20,780 shares of the stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the transaction, the director now directly owns 36,268 shares of the company’s stock, valued at $2,557,619.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jennifer Daniels sold 902 shares of the stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the transaction, the insider now directly owns 37,788 shares of the company’s stock, valued at $2,865,086.16. The disclosure for this sale can be found here. Insiders sold 181,950 shares of company stock valued at $13,237,385 over the last ninety days. Corporate insiders own 1.02% of the company’s stock.

Shares of Colgate-Palmolive (NYSE CL) opened at $77.38 on Tuesday. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.91. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. The company has a market cap of $68,053.16, a PE ratio of 29.88, a PEG ratio of 3.24 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same period in the prior year, the company earned $0.73 earnings per share. The business’s revenue was up 2.8% compared to the same quarter last year. sell-side analysts anticipate that Colgate-Palmolive will post 2.87 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a $0.40 dividend. The ex-dividend date is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.07%. Colgate-Palmolive’s payout ratio is 61.78%.

ILLEGAL ACTIVITY NOTICE: “Parametric Portfolio Associates LLC Has $226.39 Million Position in Colgate-Palmolive (CL)” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://www.watchlistnews.com/parametric-portfolio-associates-llc-has-226-39-million-position-in-colgate-palmolive-cl/1819364.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.